Over-the-counter drug

India Over The Counter Drug Market to Grow at 7.85% Through 2028 - ResearchAndMarkets.com

Retrieved on: 
Monday, September 12, 2022

India Over the Counter (OTC) Drug market stood at USD4666.15 Million in 2022 and is expected to grow at a steady CAGR of 7.85% during the forecast period.

Key Points: 
  • India Over the Counter (OTC) Drug market stood at USD4666.15 Million in 2022 and is expected to grow at a steady CAGR of 7.85% during the forecast period.
  • The over the counter (OTC) drug market is driven by growing geriatric population suffering from various diseases.
  • The digital availability of the over the counter (OTC) drugs with the penetration of online pharmacies is a booster for the over the counter (OTC) drug market as it helps users and make things easier for him/her to and thereby increasing the over the counter (OTC) drug market.
  • India Over The Counter (OTC) Drug Market, By Type of Product:

Global E-Pharmacy Market Expected to Reach around US$ 132.3 billion by 2028, market to Transcend Greater Heights with CAGR of 18.3% Over 2021-2028 - Zion Market Research

Retrieved on: 
Monday, September 20, 2021

Apparently, rise in online purchasing of medicines due to COVID pandemic will promulgate scope of e-pharmacy industry over projected timeframe.

Key Points: 
  • Apparently, rise in online purchasing of medicines due to COVID pandemic will promulgate scope of e-pharmacy industry over projected timeframe.
  • With e-pharmacy firms offering huge discounts to customers, market for e-pharmacy is anticipated to gain traction over upcoming years.
  • Furthermore, e-pharmacies provide better pricing than other offline stores and have greater access in addition to reduced product & transaction costs.
  • This review is based on a report by Zion Market Research, titled, "Global E-Pharmacy Market - by Drug Type (Prescription Drugs and Over the Counter Drugs): Industry Perspective, Comprehensive Analysis, and Forecast, 20212028."

Global E-Pharmacy Market Expected to Reach around US$ 132.3 billion by 2028, market to Transcend Greater Heights with CAGR of 18.3% Over 2021-2028 - Zion Market Research

Retrieved on: 
Monday, September 20, 2021

Apparently, rise in online purchasing of medicines due to COVID pandemic will promulgate scope of e-pharmacy industry over projected timeframe.

Key Points: 
  • Apparently, rise in online purchasing of medicines due to COVID pandemic will promulgate scope of e-pharmacy industry over projected timeframe.
  • With e-pharmacy firms offering huge discounts to customers, market for e-pharmacy is anticipated to gain traction over upcoming years.
  • Furthermore, e-pharmacies provide better pricing than other offline stores and have greater access in addition to reduced product & transaction costs.
  • This review is based on a report by Zion Market Research, titled, "Global E-Pharmacy Market - by Drug Type (Prescription Drugs and Over the Counter Drugs): Industry Perspective, Comprehensive Analysis, and Forecast, 20212028."

Dr. Reddy’s Announces the Re-Launch of Over-the-Counter Naproxen Sodium Tablets USP, 220 mg, Store-Brand Equivalent of Aleve® in the U.S. Market

Retrieved on: 
Tuesday, August 3, 2021

The re-launch of Dr. Reddys Naproxen Sodium Tablets, 220 mg (OTC), is an important addition to our Pain/Analgesics portfolio of OTC products, says Marc Kikuchi, CEO, North America Generics, Dr. Reddys Laboratories.

Key Points: 
  • The re-launch of Dr. Reddys Naproxen Sodium Tablets, 220 mg (OTC), is an important addition to our Pain/Analgesics portfolio of OTC products, says Marc Kikuchi, CEO, North America Generics, Dr. Reddys Laboratories.
  • Dr. Reddys OTC Naproxen Sodium Tablets USP, 220 mg is an over-the-counter nonsteroidal anti-inflammatory drug (NSAID) for use as a pain reliever and fever reducer.
  • Dr. Reddys Naproxen Sodium Tablets USP, 220 mg, will be available in multiple-pack sizes to allow consumers a variety of purchasing options.
  • Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology.

Knipper's New SamplicitySA Is the Next Generation of Sample Management

Retrieved on: 
Tuesday, August 3, 2021

SamplicitySA Sample Management is an integral component of Samplicity, Knipper's fully-integrated sample management platform.

Key Points: 
  • SamplicitySA Sample Management is an integral component of Samplicity, Knipper's fully-integrated sample management platform.
  • Sales personnel can spend their time selling rather than managing their sample orders, or the sample requests of their customers.
  • Knipper is currently scheduling demonstrations of the new SamplicitySA Sample Accountability program.
  • Named for its simple approach to sample management, Samplicity revolutionizes sample management for prescription and over-the-counter (OTC) pharmaceutical products with an exclusive suite of technology, services, and support.

Procaps Group to Host Virtual Investor and Analyst Day on Thursday, August 19, 2021 at 10:00 a.m. Eastern Time

Retrieved on: 
Monday, August 2, 2021

If you have difficulty connecting with the conference call, please contact MZ Group at +1 (949) 491-8235.

Key Points: 
  • If you have difficulty connecting with the conference call, please contact MZ Group at +1 (949) 491-8235.
  • Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents.
  • Procaps has a direct presence in 13 countries in Latin America and has more than 5,000 collaborators working under a sustainable model.
  • Procaps develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements and high-potency clinical solutions.

U.S. OTC Drugs Market Outlook & Forecasts 2021-2026 - COVID-19 has Considerably Influenced the Sales of OTC Drugs with the Increased Focus on Personal Health - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 27, 2021

In 2020, online pharmacies and hospital pharmacies segments accounted for the most significant U.S. OTC drugs market shares of 20.60% and 18.50%, respectively.

Key Points: 
  • In 2020, online pharmacies and hospital pharmacies segments accounted for the most significant U.S. OTC drugs market shares of 20.60% and 18.50%, respectively.
  • Online retail giants like Amazon, which recently launched a private label line called Basic Care, contribute to the US OTC drugs market trend.
  • In the past 30 years, the FDA has converted more than 700 prescription (Rx) products to OTC status.
  • What is the impact of COVID-19 on the U.S. OTC drugs market?

Genexa, the World’s First and Only Clean Medicine Company, Announces Record-breaking Series A Round

Retrieved on: 
Wednesday, July 14, 2021

Genexa , the worlds first clean, over-the-counter pharmaceutical company, has just completed its unprecedented $60 million Series A of funding to advance its market leadership in this emerging space.

Key Points: 
  • Genexa , the worlds first clean, over-the-counter pharmaceutical company, has just completed its unprecedented $60 million Series A of funding to advance its market leadership in this emerging space.
  • Jared Stein, Co-Founder and Managing Partner of Monogram Capital led the round and was joined by some of the worlds most well-regarded investors, including Unilever Ventures, Verlinvest, Northcastle Partners, and Point King Capital.
  • Genexa is heralding in a sea change moment in medicine, giving consumers access to the first clean, better-for-you, efficacious option ever in the OTC market.
  • All of our products are made to the highest standards of medicine with no artificial dyes, common allergens, or unnecessary inactive ingredients.

COVID pandemic heightens a lack of confidence amongst the public about which medicines to take and how to use them

Retrieved on: 
Thursday, July 8, 2021

With more people now treating themselves at home, increasing numbers have questions and concerns when it comes tousing over the counter medicines the right way.

Key Points: 
  • With more people now treating themselves at home, increasing numbers have questions and concerns when it comes tousing over the counter medicines the right way.
  • Pain is one of the most common medicalareas in which peopleseek information about ways toself-manage with medication.
  • You can find a lot of information online, but it is not always easy to know which sources to trust.
  • 5What Covid-19 Taught Us About Telemedicine; The pandemic gave doctors a crash course in what does and doesn't work.

COVID pandemic heightens a lack of confidence amongst the public about which medicines to take and how to use them

Retrieved on: 
Thursday, July 8, 2021

With more people now treating themselves at home, increasing numbers have questions and concerns when it comes tousing over the counter medicines the right way.

Key Points: 
  • With more people now treating themselves at home, increasing numbers have questions and concerns when it comes tousing over the counter medicines the right way.
  • One area of health that is particularly in focus is the management of pain.
  • Pain is one of the most common medicalareas in which peopleseek information about ways toself-manage with medication.
  • You can find a lot of information online, but it is not always easy to know which sources to trust.